Featured Articles

Diagnosis and Management of Primary Hyperhidrosis: Practical Guidance and Current Therapy Update

By July 27, 2020No Comments

Skin of Color Update

Featured Article

With the busy practitioner and dermatology resident in mind, we provide here a disease state primer for hyperhidrosis, a top-line review of the breadth of literature underscoring the overall burden of the disease, a practical guide to differential diagnosis, and an update on current treatment approaches, including for the most common form of the condition, primary axillary hyperhidrosis.

Read more

A case study on the importance of early and effective management strategies for those suffering with hyperhidrosis.

Joe Gorelick MSN FNP-C, Adam Friedman MD

In the most simplistic definition, hyperhidrosis is excessive sweating. However, it is largely misunderstood, often goes undiagnosed, and continues to be inadequately managed for many patients. Approximately half of those who self-identify as having excessive sweating do not discuss their symptoms with healthcare professionals despite the severe negative impact on their quality of life; reasons for this include the misconception that hyperhidrosis is not a medical condition and that no treatments exist.

In one study, only half of patients who reported their symptoms to a healthcare professional were ultimately diagnosed with primary hyperhidrosis, which may reflect a reality of widespread underdiagnosis of the condition.1 In a survey conducted by the International Hyperhidrosis Society (IHhS), 48.9% of patients waited 10 or more years before seeking medical help for their excessive sweating.2

With the busy practitioner and dermatology resident in mind, here we provide a disease state primer for hyperhidrosis, a top-line review of the breadth of literature underscoring the overall burden of the disease, a practical guide to differential diagnosis, and an update on current treatment approaches.3, 4 In addition, a case study in primary axillary (underarm) hyperhidrosis is presented to provide a real-life perspective from the clinic on the importance of early and effective management strategies for those suffering with hyperhidrosis.

Read Article Now
Article Cited in this Post

You May Also Like

Journal of Drugs in Dermatology JDD Article About Antioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone back or torso with a seborrheic keratoses.

Antioxidant, Keratolytic, and Hydrating Treatment for Seborrheic Keratoses

| Featured Articles, JDD Highlights, Latest News, The Latest | No Comments
JDD Spotlight: A Novel Topical Approach for Seborrheic Keratoses? Could a new topical formula change the way we manage seborrheic keratoses? In a pilot study, a unique blend of antioxidants,…

JDD in the News: Micropeptide Addresses Aging, Inflammation

| Acne, Derm Community, Featured Articles, JDD Highlights, JDD in the Media, The Latest | No Comments
A recent Journal of Drugs in Dermatology study about a micropeptide with anti-aging and anti-inflammatory effects made news in Dermatology Times. The study, “Acetyl Dipeptide-31 Amide: A Novel Cosmetic Anti-Inflammatory…
Journal of Drugs in Dermatology JDD Article About Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses. Image from the Full Spectrum of Dermatology: A Diverse and Inclusive Atlas of a darker skin tone elbow with psoriasis.

Guselkumab Efficacy by Psoriasis Disease Severity and Treatment History: VOYAGE 1 and 2 Post Hoc Analyses

| Featured Articles, JDD Highlights, Latest News, Psoriasis, The Latest | No Comments
JDD Spotlight: Guselkumab’s 5-Year Promise in Psoriasis Curious about long-term breakthroughs in psoriasis care? A recent pooled analysis from the Phase 3 VOYAGE studies hints that guselkumab might be a…

Leave a Reply